Registered Users Log-in:

E-mail Address:
 

Password:
 

  
Forgot Password?
Registration
 
Patient Assistance Information

 
 
 
ASSIST Program


,
Phone : (877)864-8437
Fax:
Eligibility
> Insurance status will be considered on a case by case status. Patients must meet income requirements that have not been disclosed and must reside and receive treatment in the US.
Who Can Apply
> Patients must call for a prescreening.
Required
> Doctors must provide patients with a prescription and patients must call to enroll.
Supply
> Not specified
Ship To
> Not specified
Note
> For information on Patient Assistance Programs that may be available for United Therapeutics Corporation products (Orenitram®, Remodulin®, Tyvaso®) or Lung Biotechnology's product (Adcirca®), please contact ASSIST at 877 864-8437
 
Includes Support for This Drug
NOTE: Linked drugs are available for Prescribers to Apply Online now.
Click drug logo or drug name to start online application.
 
Adcirca tablet
Orenitram tablet; extended release
Remodulin injection
Tyvaso solution; inhalation